Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)
28 Agosto 2013 - 7:01AM
Edgar (US Regulatory)
Filed pursuant to Rule 433
Registration Statement No. 333-180300-03
FINANCIAL PRODUCTS
FACT SHEET (K341)
|
|
Offering Period: August 19, 2013 – September 9, 2013
3.5 Year Buffered Accelerated Return Equity Securities (BARES)
Linked to the S&P 500
®
Index
Product Summary
|
•
|
3.5 year Buffered Accelerated Return Equity Securities (BARES)
linked to the performance of the S&P 500
®
Index.
|
|
•
|
If the Final Level is less than the Initial Level by not
more than the Buffer Amount, then the investor will be entitled to receive the principal amount at maturity.
|
|
•
|
If the Final Level is less than the Initial Level by more
than the Buffer Amount, then the principal amount the investor will be entitled to receive will decrease 1% for every 1% decline
in the Underlying beyond the Buffer Amount.
|
|
•
|
If the Final Level is equal to or greater than the Initial
Level, then the investor will be entitled to participate in the appreciation of the Underlying.
|
|
•
|
Any payment on the securities is subject to our ability to
pay our obligations as they become due.
|
|
•
|
Credit Suisse currently estimates the value of the securities
on the Trade Date will be less than the price you pay for the securities, reflecting the deduction of underwriting discounts and
commissions and other costs of creating and marketing the securities.
|
Terms
Issuer:
|
Credit Suisse AG (“Credit Suisse”), acting through one of its branches.
|
Trade Date:
|
Expected to be September 10, 2013
|
Settlement Date:
|
Expected to be September 13, 2013
|
Underlying:
|
The S&P 500
®
Index.
|
Redemption Amount:
|
An amount in cash equal to the principal amount of the securities held multiplied by the sum of 1 plus the Underlying Return.
|
Underlying Return:
|
If (a) the Final Level is equal to or greater than the Initial Level, then: [(Final Level – Initial Level) / Initial Level]; (b) the Final Level is less than the Initial Level by not more than the Buffer Amount, then: zero; or (c) if the Final Level is less than the Initial Level by more than the Buffer Amount, then: [(Final Level – Initial Level) / Initial Level] + Buffer Amount.
|
Buffer Amount:
|
Expected to be between 15.0% and 20.0% (to be determined on the Trade Date).
|
Initial Level:
|
The closing level of the Underlying on the Trade Date.
|
Final Level:
|
The closing level of the Underlying on the Valuation Date.
|
Valuation Date:
|
March 8, 2017
|
Maturity Date:
|
March 13, 2017
|
CUSIP:
|
22547QA89
|
Benefits
|
•
|
Offers the potential for participation in the appreciation
of the Underlying, uncapped.
|
|
•
|
Reduced downside risk due to a Buffer Amount of [15.0-20.0]%
(to be determined on the Trade Date).
|
Hypothetical Returns at Maturity
Percentage Change
from Initial
Level to
Final Level
|
Underlying
Return (1)(2)
|
Redemption Amount
per
$1,000 Principal
Amount (1)(2)
|
50%
|
50.0%
|
$1,500
|
40%
|
40.0%
|
$1,400
|
30%
|
30.0%
|
$1,300
|
20%
|
20.0%
|
$1,200
|
10%
|
10.0%
|
$1,100
|
0%
|
0.0%
|
$1,000
|
-10%
|
0.0%
|
$1,000
|
-17.5%
|
0.0%
|
$1,000
|
-20%
|
-2.5%
|
$975
|
-30%
|
-12.5%
|
$875
|
-40%
|
-22.5%
|
$775
|
|
(1)
|
Assumes
a buffer of 17.5%
(the midpoint
of the expected
range) (to be
determined on
Trade Date).
|
|
(2)
|
The hypothetical
Redemption Amounts set forth above are for illustrative
purposes only and may not be the actual returns applicable
to the investor. The numbers appearing in the table
have been rounded for ease of analysis.
|
Product Risks
|
•
|
Investment may result in a loss of up to [80.0-85.0]% of
principal (to be determined on the Trade Date) and the Redemption Amount will be less than the principal amount if the Final Level
is less than the Initial Level by more than the Buffer Amount.
|
|
•
|
The value of the securities and the payment of any amount
due on the securities are subject to the credit risk of Credit Suisse.
|
|
•
|
The securities do not pay interest.
|
|
•
|
(See “Additional Risk Considerations” on the next
page.)
|
Product Profile
Horizon
(months)
|
|
3.5 Years
|
Principal
Repayment
|
|
Principal at Risk
|
Investment
Objective
|
|
Appreciation
|
Market
Outlook
|
|
Bullish
|
FINANCIAL PRODUCTS
FACT SHEET
|
|
Offering Period:
August 19, 2013 – September 9, 2013
Buffered Accelerated Return Equity Securities (BARES)
Additional Risk Considerations
|
•
|
Prior to maturity, costs such as concessions and hedging
may affect the value of the securities.
|
|
•
|
Liquidity – The securities will not be listed on any
securities exchange. Credit Suisse (or its affiliates) intends to offer to purchase the securities in the secondary market but
is not required to do so. Many factors, most of which are beyond the control of the Issuer, will influence the value of the securities
and the price at which the securities may be purchased or sold in the secondary market. For example, the creditworthiness of the
Issuer, including actual or anticipated downgrades to the Issuer’s credit ratings, may be a contributing factor.
|
|
•
|
Potential Conflicts – We and our affiliates play a variety
of roles in connection with the issuance of the securities including acting as calculation agent, hedging our obligations under
the securities and determining the estimated value of the securities. The agent for this offering, Credit Suisse Securities (USA)
LLC (“CSSU”), is our affiliate. In accordance with FINRA Rule 5121, CSSU may not make sales in this offering to any
discretionary account without prior written approval of the customer.
|
|
•
|
The securities will be affected by a number of economic,
financial, political, regulatory, and judicial factors that may either offset or magnify each other.
|
|
•
|
As a holder of the securities, you will not have voting rights
or rights to receive cash dividends or other distributions with respect to the equity securities comprising the Underlying.
|
The risks set forth in the section entitled “Product Risks” on the preceding page and this section “Additional Risk Considerations” are only intended as summaries of some of the risks relating to an investment in the securities.
Prior to investing in the securities, you should, in particular, review the “Product Risks” and “Additional Risk Considerations” sections herein, the “Selected Risk Considerations” section in the pricing supplement, and the “Risk Factors” section of the product supplement, which set forth risks related to an investment in the securities.
Disclaimer
IRS Circular 230 Disclosure: Credit Suisse and its affiliates do not provide tax advice. Accordingly, any discussion of U.S. tax matters contained herein (including any attachments) is not intended or written to be used and cannot be used, in connection
with the promotion, marketing or recommendation by anyone unaffiliated with Credit Suisse of any of the matters address herein or for the purpose of avoiding U.S. tax-related penalties.
Investment suitability must be determined individually for each investor, and the financial instruments described herein may not be suitable for all investors. The products described herein should generally be held to maturity as early sales could result
in lower than anticipated returns. This information is not intended to provide and should not be relied upon as providing accounting, legal, regulatory or tax advice. Investors should consult with their own advisors as to these matters.
This material is not a product of Credit Suisse Research Departments. Financial Products may involve a high degree of risk, and may be appropriate investments only for sophisticated investors who are capable of understanding and assuming the risks
involved. Credit Suisse and its affiliates may have positions (long or short), effect transactions or make markets in securities or financial instruments mentioned herein (or options with respect thereto), or provide advice or loans to, or participate in
the underwriting or restructuring of the obligations, issuers of the stocks comprising the applicable index, indices or fund mentioned herein. Credit Suisse is a member of FINRA, NYSE and SIPC. Clients should contact their salespersons at, and execute
transactions through, a Credit Suisse entity qualified in their home jurisdiction unless governing law permits otherwise.
You may revoke your offer to purchase the securities at any time prior to the time at which we accept such offer on the date the securities are priced. We reserve the right to change the terms of, or reject any offer to purchase the securities prior
to their issuance. In the event of any changes to the terms of the securities, we will notify you and you will be asked to accept such changes in connection with your purchase. You may also choose to reject such changes in which case we may reject your
offer to purchase.
This document is a summary of the terms of the securities and factors that you should consider before deciding to invest in the securities. Credit Suisse has filed a registration statement (including pricing supplement, product supplement, underlying
supplement, prospectus supplement and prospectus) with the Securities and Exchange Commission, or SEC, for the offering to which this offering summary relates. Before you invest, you should read this summary together with the Preliminary Pricing
Supplement dated August 19, 2013, Underlying Supplement dated July 29, 2013, Product Supplement No. AK-I dated March 23, 2012, Prospectus Supplement dated March 23, 2012 and Prospectus dated March 23, 2012 to understand fully the terms of the notes and
other considerations that are important in making a decision about investing in the securities. You may get these documents without cost by visiting EDGAR on the SEC Web site at
www.sec.gov
.
Alternatively, Credit Suisse, any agent or any dealer participating in this offering will arrange to send you the pricing supplement, product supplement, underlying supplement, prospectus supplement and prospectus if you so request by calling toll-free 1
(800) 221-1037.
You may access the pricing supplement related to the offering summarized herein on the SEC website at:
http://www.sec.gov/Archives/edgar/data/1053092/000095010313004965/dp40237_424b2-k341.htm
You may access the underlying supplement, product supplement, prospectus supplement and prospectus on the SEC website at
www.sec.gov
or by clicking on the hyperlinks to each of the respective documents
incorporated by reference in the pricing supplement.
Selected Daily Government Fund (NASDAQ:SDGXX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Selected Daily Government Fund (NASDAQ:SDGXX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024